A resting heart rate of 50 beats per minute can be a sign of excellent cardiovascular fitness — or a red flag for cardiac disease. The difference often comes down to the vagus nerve. As the primary parasympathetic brake on the heart, the vagus nerve releases acetylcholine at the sinoatrial (SA) node, activating muscarinic M2 receptors that open potassium channels, hyperpolarise pacemaker cells, and slow the rate of depolarisation. This vagal braking is the main reason your heart rate drops during rest, sleep, and recovery. Bradycardia — a heart rate below 60 bpm — is the result when vagal tone is high. Whether that matters depends entirely on context.
How the Vagus Nerve Slows the Heart
The cardiac vagal branches originate from the nucleus ambiguus and the dorsal motor nucleus of the vagus in the medulla. They synapse on postganglionic neurons in the cardiac plexus near the SA node and atrioventricular (AV) node. Acetylcholine released at these synapses has three primary effects: it slows SA node firing rate (negative chronotropy), reduces the speed of conduction through the AV node (negative dromotropy), and slightly decreases atrial contractility. The vagal effect on heart rate is fast — within one to two heartbeats — because acetylcholine is rapidly degraded by acetylcholinesterase. This allows beat-to-beat vagal modulation of heart rate, which is what heart rate variability (HRV) measurements actually capture.
Athlete’s Heart: When Slow Is Strong
Endurance athletes routinely have resting heart rates of 40–60 bpm, and some elite athletes have documented rates in the low 30s. This is physiological bradycardia — a beneficial adaptation. Chronic aerobic training increases stroke volume (the heart pumps more blood per beat), so fewer beats are needed to maintain cardiac output at rest. Simultaneously, vagal tone increases with fitness, further slowing the resting rate. Athletes typically have high HRV, particularly elevated RMSSD (the time-domain measure of vagal modulation), often exceeding 60–80 ms compared to typical adult values of 25–45 ms.
The key features that distinguish athletic bradycardia from pathological bradycardia: the person is asymptomatic, heart rate rises appropriately with exercise (chronotropic competence), there are no significant pauses on Holter monitoring, and the ECG shows no conduction disease. Athletic bradycardia requires no treatment — it is a marker of cardiovascular health.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- HRV biofeedback
- Polyvagal-informed therapy
- Somatic therapy
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Sleep and Circadian Vagal Rhythms
Heart rate normally drops 10–20 percent during sleep as vagal tone rises and sympathetic activity decreases. Nocturnal heart rates in the low 40s are common in healthy adults and are not pathological. Heart rate reaches its nadir during slow-wave sleep (deep NREM sleep), when parasympathetic dominance peaks. Brief sinus pauses of up to two seconds during sleep are considered physiological. This circadian vagal pattern is disrupted in conditions like obstructive sleep apnoea, where repetitive hypoxia triggers sympathetic surges that fragment the normal nocturnal vagal dominance.
When Bradycardia Becomes Pathological
Pathological bradycardia is slow heart rate that produces symptoms — and the symptoms, not the number, drive treatment decisions. A heart rate of 45 in a fit 30-year-old who feels fine is normal. A heart rate of 55 in a 75-year-old who faints on standing may be dangerously slow for them.
Common causes of pathological bradycardia include sick sinus syndrome (SA node degeneration, most common in elderly patients), AV conduction block (first-degree, second-degree Mobitz types I and II, third-degree/complete heart block), drug-induced bradycardia (beta-blockers, calcium channel blockers, digoxin, amiodarone, cholinesterase inhibitors), hypothyroidism (reduced metabolic rate slows SA node firing), raised intracranial pressure (Cushing reflex — bradycardia with hypertension), and inferior myocardial infarction (the right coronary artery supplies the SA node in most people).
Vasovagal Bradycardia and Syncope
Vasovagal syncope involves an acute, exaggerated vagal reflex: a trigger (pain, prolonged standing, emotional distress, blood draw) provokes a paradoxical surge in vagal output that causes sudden bradycardia and vasodilation simultaneously. The result is a precipitous drop in blood pressure and cerebral perfusion, producing lightheadedness, tunnel vision, nausea, and — if the reflex is strong enough — loss of consciousness. The REVERT trial (2015, The Lancet) demonstrated that the modified Valsalva manoeuvre (strain followed by passive leg raise) terminates supraventricular tachycardia at a 43 percent rate, illustrating how vagal manoeuvres can be therapeutically harnessed, but in vasovagal syncope the vagal reflex is the problem rather than the solution.
Carotid sinus hypersensitivity is a related condition in which pressure on the carotid sinus — from a tight collar, head turning, or shaving — triggers an excessive vagal reflex causing bradycardia, hypotension, or both. It is more common in elderly men and can cause unexplained falls.
Diagnostic Assessment
Evaluation of suspected pathological bradycardia typically includes a 12-lead ECG to identify conduction abnormalities, 24–48-hour Holter monitoring to capture intermittent bradycardia and pauses, exercise stress testing to assess chronotropic competence (whether heart rate rises appropriately with exertion), thyroid function tests, medication review, and in some cases electrophysiology studies. The European Society of Cardiology defines clinically significant bradycardia by its symptoms, not by an arbitrary heart rate cutoff: a rate of 50 bpm with dizziness, exertional fatigue, or syncope is more concerning than a rate of 38 bpm in an asymptomatic marathon runner.
Treatment: When a Pacemaker Is Needed
The first step in managing symptomatic bradycardia is addressing reversible causes: discontinuing or reducing offending medications, treating hypothyroidism, and managing any acute cardiac event. For irreversible symptomatic bradycardia — particularly sick sinus syndrome and high-grade AV block — a permanent pacemaker is the definitive treatment. Modern dual-chamber pacemakers sense and pace both the atrium and ventricle, maintaining AV synchrony. Indications for pacing include symptomatic bradycardia with documented correlation between symptoms and heart rate, third-degree AV block, and alternating bundle branch block.
For vasovagal syncope, treatment focuses on avoiding triggers, increasing fluid and salt intake, physical counterpressure manoeuvres (leg crossing, hand gripping when prodromal symptoms appear), and sometimes medications like midodrine or fludrocortisone. Pacemaker implantation for vasovagal syncope is reserved for patients over 40 with recurrent severe episodes and documented cardioinhibitory responses on tilt-table testing.
Want to understand your vagus nerve’s influence on heart rate, stress, and recovery? Get the Vagus Nerve & Me eBook for a science-grounded guide to the nerve that sets your cardiac rhythm.
